Wilson Sonsini Goodrich & Rosati represented the investors in the transaction.D3 Bio, Inc, a clinical-stage biotechnology announced its closing of a $62 million Series A financing round….
Wilson Sonsini Goodrich & Rosati represented the investors in the transaction.D3 Bio, Inc, a clinical-stage biotechnology announced its closing of a $62 million Series A financing round….
You must be a Standard 1 Year member to access this content.
…
You must be a Standard 1 Year member to access this content.